Bacteria can also break down nitrite to produce nitric oxide, which improves circulation, including blood flow to the brain.
Anavex Life Sciences Corp.'s stock rises 50% as EMA reviews Alzheimer's drug blarcamesine. Click for my updated look at AVXL stock and why I have upgraded it.
Scientists have identified a biomarker for Alzheimer's that may help doctors spot the early signs of protein buildup in the ...
Alzheimer's Association experts have issued a warning about one largely-unknown symptom of early-stage dementia ...
US researchers behind the new analysis said they hoped the findings would help patients weigh up the potential benefits of ...
In the past two years, the Food and Drug Administration has approved two novel Alzheimer's therapies, based on data from ...
When people think about cognitive decline, they often imagine the obvious symptoms: forgetfulness, confusion, or difficulty ...
By Heather Leigh Click here for updates on this story CLEARWATER, Florida (WFTS) — If you live with or take care of someone with dementia or Alzheimer’s disease, you know interactions with strangers ...
As the body of research expands on the potential of glucagon-like peptide-1 receptor agonists to address various health ...
The biomarker test is a spinal tap test (also called a lumbar puncture) that uses a needle to remove cerebrospinal fluid (i.e ...
Within five to 10 years people most at risk of dementia could be given preventive drugs to ward off the disease.
Leqembi (lecanemab) and Kisunla (donanemab) are proven to slow cognitive and functional decline by 27 and 35%, respectively.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback